College of Pharmacy, Jabir Ibn Hayyan Medical University, Najaf, Iraq.
Arch Razi Inst. 2021 Nov 30;76(5):1545-1549. doi: 10.22092/ari.2021.356070.1769. eCollection 2021 Nov.
Outbreaks of a respiratory ailment in Wuhan, China, known as the Corona virus Disease-2019 (COVID-19), began in late December 2019. Since then, several pieces of advice have been made to boost the immune system to fight more efficiently with this infection. Previously published studies showed that vitamin D3 (Vit D3) level was low in COVID-19 patients. One of the most important factors in COVID-19 severity would be the inflammatory response. It is well documented that the inflammatory cytokine storm increases the severity of COVID-19. Cytokine storm results from dysregulation of the innate immune system with an outpouring of proinflammatory cytokines and chemokines, leading to abnormal activation of the adaptive immune pathway. It has been approved that Vit D3 has immunomodulatory functions and plays an anti-inflammatory role, particularly in viral infections. Therefore, the current study was designed to investigate the possible role of Vit D3 deficiency in the COVID-19 patients' innate immunity. This study included 180 participants who were divided into group (A) consisted of 60 COVID-19 positive patients with normal level of Vit D3, group (B) consisted of 60 COVID-19 positive patients with Vit D3 deficiency, and group (C) consisted of 60 COVID-19 positive patients that had received Vit D3 therapy. The results showed that the rate of hospitalization in the group (B) (41.3%) was significantly increased, compared to group (A) (12.5%). In this regard, Vit D3 therapy led to a significant increase in the level of Vit D3, and the patients who received Vit D3 were recovered from hospital 5 days on average sooner than those in the group (B). Therefore, the consumption of Vit D3 as a daily supplement would be a reasonable suggestion for these days of the COVID-19 pandemic to increase the power of immunity of the body.
中国武汉爆发的一种呼吸道疾病,被称为 2019 年冠状病毒病(COVID-19),始于 2019 年 12 月下旬。自那时以来,已经提出了一些建议来增强免疫系统,以更有效地对抗这种感染。以前发表的研究表明,COVID-19 患者的维生素 D3(Vit D3)水平较低。COVID-19 严重程度的最重要因素之一将是炎症反应。有充分的文献记载,细胞因子风暴会增加 COVID-19 的严重程度。细胞因子风暴是由于先天免疫系统失调,促炎细胞因子和趋化因子大量释放,导致适应性免疫途径异常激活而引起的。已经证实 Vit D3 具有免疫调节功能,并在病毒感染中发挥抗炎作用。因此,本研究旨在探讨 Vit D3 缺乏在 COVID-19 患者固有免疫中的可能作用。本研究共纳入 180 名参与者,分为 A 组(60 例 Vit D3 水平正常的 COVID-19 阳性患者)、B 组(60 例 Vit D3 缺乏的 COVID-19 阳性患者)和 C 组(60 例接受 Vit D3 治疗的 COVID-19 阳性患者)。结果显示,B 组(41.3%)的住院率明显高于 A 组(12.5%)。在这方面,Vit D3 治疗导致 Vit D3 水平显著升高,接受 Vit D3 治疗的患者平均比 B 组提前 5 天出院。因此,在 COVID-19 大流行期间,每天补充 Vit D3 作为补充剂将是增强身体免疫力的合理建议。